Stock Earnings

Question 1

What are AxoGen Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), AxoGen Inc has a total asset of $203, Net loss of $-9

Question 2

What are the key financial ratios for AXGN?

Accepted Answer

AxoGen Inc's Current ratio is 2.05, has a Net margin is -4.81, sales per share of $4.22.

Question 3

How is AxoGen Inc's revenue broken down by segment or geography?

Accepted Answer

AxoGen Inc largest revenue segment is Peripheral Nerve Regeneration and Repair, at a revenue of 187,338,000 in the most earnings release.For geography, United States is the primary market for AxoGen Inc, at a revenue of 187,338,000.

Question 4

Is AxoGen Inc profitable?

Accepted Answer

no, according to the latest financial statements, AxoGen Inc has a net loss of $-9

Question 5

Does AxoGen Inc have any liabilities?

Accepted Answer

yes, AxoGen Inc has liability of 99

Question 6

How many outstanding shares for AxoGen Inc?

Accepted Answer

AxoGen Inc has a total outstanding shares of 44.14

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	214	187	159	138	127	112
Revenue Growth (YoY)	19%	18%	15%	9%	13%	6%
Cost of Revenue	54	45	34	27	25	23
Gross Profit	160	141	124	111	101	88
Selling, General & Admin	129	117	117	113	103	93
Research & Development	27	27	28	27	24	17
Operating Expenses	156	145	146	141	127	111
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-2	-9	-21	-28	-27	-23
Income Tax Expense	0	0	--	--	--	--
Net Income	-2	-9	-21	-28	-27	-23
Net Income Growth	-86%	-56.99%	-25%	4%	17%	-21%
Shares Outstanding (Diluted)	49.08	44.25	42.87	42.1	41.2	40
Shares Change (YoY)	12%	3%	2%	2%	3%	2%
EPS (Diluted)	-0.04	-0.22	-0.5	-0.69	-0.65	-0.6
EPS Growth	-85%	-56%	-27%	6%	8%	-19%
Free Cash Flow	2	0	-20	-37	-41	-32
Free Cash Flow Per Share	0.04	0	-0.46	-0.87	-0.99	-0.8
Gross Margin	74.76%	75.4%	77.98%	80.43%	79.52%	78.57%
Operating Margin	1.4%	-1.6%	-13.2%	-21.01%	-19.68%	-20.53%
Profit Margin	-0.93%	-4.81%	-13.2%	-20.28%	-21.25%	-20.53%
Free Cash Flow Margin	0.93%	0%	-12.57%	-26.81%	-32.28%	-28.57%
EBITDA	9	3	-17	-26	-23	-22
EBITDA Margin	4.2%	1.6%	-10.69%	-18.84%	-18.11%	-19.64%
D&A For EBITDA	6	6	4	3	2	1
EBIT	3	-3	-21	-29	-25	-23
EBIT Margin	1.4%	-1.6%	-13.2%	-21.01%	-19.68%	-20.53%
Effective Tax Rate	0%	0%	--	--	--	--

AxoGen Inc (AXGN) Price

AXGN Stock Price Chart

AXGN Income

Follow-Up Questions